(Q43530570)

24 November 2017

IgE-mediated anaphylaxis and allergic reactions to idursulfase in patients with Hunter syndrome (English)

1 reference

24 November 2017

1 reference

1 reference

1 reference

J Kim

1

1 reference

24 November 2017

M R Park

2

1 reference

24 November 2017

D S Kim

3

1 reference

24 November 2017

J O Lee

4

1 reference

24 November 2017

S H Maeng

5

1 reference

24 November 2017

S Y Cho

6

1 reference

24 November 2017

Y Han

7

1 reference

24 November 2017

K Ahn

8

1 reference

24 November 2017

D K Jin

9

1 reference

24 November 2017

language of work or name

1 reference

29 April 2013

1 reference

24 November 2017

1 reference

24 November 2017

68

1 reference

24 November 2017

6

1 reference

24 November 2017

796-802

1 reference

Overview of the mucopolysaccharidoses

24 November 2017

1 reference

Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II.

21 January 2018

1 reference

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

21 January 2018

1 reference

Japan Elaprase Treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II).

21 January 2018

1 reference

Idursulfase treatment of Hunter syndrome in children younger than 6 years: results from the Hunter Outcome Survey

21 January 2018

1 reference

Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS).

21 January 2018

1 reference

Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.

21 January 2018

1 reference

Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions

21 January 2018

1 reference

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

Immunologic evaluation of drug allergy

21 January 2018

1 reference

Adverse side-effects to biological agents

21 January 2018

1 reference

Anaphylactic shock after retreatment with OKT3 monoclonal antibody

21 January 2018

1 reference

Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I.

21 January 2018

1 reference

Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA

21 January 2018

1 reference

Side-chain-specific reactions to betalactams: 14 years later

21 January 2018

1 reference

Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions.

21 January 2018

1 reference

Hypersensitivity reactions to biological agents with special emphasis on tumor necrosis factor-alpha antagonists

21 January 2018

1 reference

Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: A perspective from the Hunter Outcome Survey (HOS)

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ALL.12155

1 reference

24 November 2017

1 reference